BRIEF-David Horn Solomon Resigns As CEO Of Akari Therapeutics
May 11 (Reuters) – Akari Therapeutics PLC: * AKARI THERAPEUTICS SAYS ON MAY 8, DAVID HORN SOLOMON, RESIGNED AS CEO AND AS A MEMBER OF BOARD EFFECTIVE IMMEDIATELY – SEC FILING * AKARI THERAPEUTICS – ALSO EFFECTIVE ON MAY 8, BOARD APPOINTED CLIVE RICHARDSON TO SERVE AS INTERIM CEO *
Name: David Horn Solomon
Continent: North America
Country: USA
Company: Akari Therapeutics
Position: CEO
Reason: Resigned
Announcement Date: May 10, 2018, 10:00pm
Resignation Date: May 10, 2018, 10:00pm